₹ 3,344.07 Cr
0.0%
S&P 500 TRI
INF109K01E43
5000.0
1000.0
100
Ritesh Lunawat
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential US Bluechip Equity Fund - IDCW | 9.06 | 18.98 | 14.8 |
| Benchmark | - | - | - |
Equity
Debt
Others
The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
| Company | Holdings (%) |
|---|---|
| Alphabet Inc | 2.97 |
| Huntington Ingalls Industries Inc | 2.96 |
| West Pharmaceutical Services Inc | 2.83 |
| Estee Lauder Cos Inc | 2.7 |
| Agilent Technologies Co Ltd | 2.58 |
| US Bancorp Inc | 2.49 |
| Zimmer Biomet Holdings Inc | 2.46 |
| Pfizer Inc | 2.46 |
| Nike Inc | 2.4 |
| GE HealthCare Technologies Inc | 2.4 |
| Sector | Holdings (%) |
|---|
| Scheme Name | 5Y (%) |
|---|---|
| ICICI Pru US Bluechip Equity IDCW | 14.8 |
| ABSL Intl Equity Gr Reg | 12.65 |
| Nippon India Japan Equity Gr Gr | 8.56 |
| Franklin Asian Equity Gr | 4.41 |
| Nippon India US Equity Opportunities Fund Gr Gr | 13.27 |
| ICICI Pru US Bluechip Equity Gr | 14.8 |